198 related articles for article (PubMed ID: 23474562)
1. Ampullary and periampullary adenocarcinoma: new challenges in management of recurrence.
Ramfidis VS; Syrigos KN; Saif MW
JOP; 2013 Mar; 14(2):158-60. PubMed ID: 23474562
[TBL] [Abstract][Full Text] [Related]
2. Treatment utilization and surgical outcome of ampullary and duodenal adenocarcinoma.
Shaib WL; Sharma R; Brutcher E; Kim S; Maithel SK; Chen Z; Kooby DA; Kauh J; Landry J; El-Rayes BF
J Surg Oncol; 2014 May; 109(6):556-60. PubMed ID: 24338561
[TBL] [Abstract][Full Text] [Related]
3. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas.
Wang SE; Shyr YM; Su CH; Chen TH; Wu CW
Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381
[TBL] [Abstract][Full Text] [Related]
4. 15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas.
Onkendi EO; Boostrom SY; Sarr MG; Farnell MB; Nagorney DM; Donohue JH; Kendrick ML; Reid-Lombardo KM; Harmsen WS; Que FG
J Gastrointest Surg; 2012 Apr; 16(4):682-91. PubMed ID: 22350721
[TBL] [Abstract][Full Text] [Related]
5. Ampullary cancer: an overview.
Ahn DH; Bekaii-Saab T
Am Soc Clin Oncol Educ Book; 2014; ():112-5. PubMed ID: 24857067
[TBL] [Abstract][Full Text] [Related]
6. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma.
Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Clin Transl Oncol; 2012 May; 14(5):391-5. PubMed ID: 22551547
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of Ampullary Adenocarcinoma].
Shin DW
Korean J Gastroenterol; 2023 Oct; 82(4):159-170. PubMed ID: 37876255
[TBL] [Abstract][Full Text] [Related]
9. Histopathologic Analysis of Pancreaticoduodenectomy Specimen.
Dhakhwa R; Kafle N
JNMA J Nepal Med Assoc; 2016; 55(204):79-85. PubMed ID: 28029673
[TBL] [Abstract][Full Text] [Related]
10. Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy.
Chandrasegaram MD; Chiam SC; Chen JW; Khalid A; Mittinty ML; Neo EL; Tan CP; Dolan PM; Brooke-Smith ME; Kanhere H; Worthley CS
World J Surg Oncol; 2015 Feb; 13():85. PubMed ID: 25890023
[TBL] [Abstract][Full Text] [Related]
11. Ampullary Mixed Adenoneuroendocrine Carcinoma: Surprise Histology, Familiar Management.
Mahansaria SS; Agrawal N; Arora A; Bihari C; Appukuttan M; Chattopadhyay TK
Int J Surg Pathol; 2017 Oct; 25(7):585-591. PubMed ID: 28552015
[TBL] [Abstract][Full Text] [Related]
12. Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin.
Schmocker RK; Wright MJ; Ding D; Javed AA; Cameron JL; Lafaro K; Burns WR; He J; Wolfgang CL; Burkhart RA
J Surg Oncol; 2021 Feb; 123(2):416-424. PubMed ID: 33125737
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.
Park JS; Yoon DS; Kim KS; Choi JS; Lee WJ; Chi HS; Kim BR
J Surg Oncol; 2007 Mar; 95(4):286-90. PubMed ID: 17326125
[TBL] [Abstract][Full Text] [Related]
14. Liver perfusion chemotherapy for selected patients at a high-risk of liver metastasis after resection of duodenal and ampullary cancers.
Noda T; Ohigashi H; Ishikawa O; Eguchi H; Yamada T; Sasaki Y; Yano M; Imaoka S
Ann Surg; 2007 Nov; 246(5):799-805. PubMed ID: 17968172
[TBL] [Abstract][Full Text] [Related]
15. Survival after resection of ampullary carcinoma: a national population-based study.
O'Connell JB; Maggard MA; Manunga J; Tomlinson JS; Reber HA; Ko CY; Hines OJ
Ann Surg Oncol; 2008 Jul; 15(7):1820-7. PubMed ID: 18369675
[TBL] [Abstract][Full Text] [Related]
16. Periampullary tumours: report of two cases.
Kassa E
East Afr Med J; 1996 May; 73(5):333-5. PubMed ID: 8756040
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of prognosis-associated factors in pancreatic head and peri-ampullary cancer].
Roder JD; Siewert JR
Chirurg; 1992 May; 63(5):410-5. PubMed ID: 1376655
[TBL] [Abstract][Full Text] [Related]
18. The role of pancreaticoduodenectomy for locally recurrent or metastatic carcinoma to the periampullary region.
Nakeeb A; Lillemoe KD; Cameron JL
J Am Coll Surg; 1995 Feb; 180(2):188-92. PubMed ID: 7850053
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of histological blood vessel invasion in patients with ampullary adenocarcinoma.
Kawaguchi T; Ochiai T; Ikoma H; Inoue K; Morimura R; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Nakanishi M; Ichikawa D; Okamoto K; Fujiwara H; Kokuba Y; Sonoyama T; Otsuji E
Hepatogastroenterology; 2010; 57(104):1347-50. PubMed ID: 21443083
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal recurrence of ampullary carcinoma following curative pancreatoduodenectomy.
Yoshida T; Matsumoto T; Sasaki A; Aramaki M; Kawano K; Kitano S
Hepatogastroenterology; 1999; 46(30):3274-5. PubMed ID: 10626200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
